Covered recipient · General Payments record
PATRICIA PICHILINGUE RETO
Allopathic & Osteopathic Physicians Pediatrics Pediatric Infectious Diseases
General Payments · PY2019–2024
$9,846.34
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,710.00 | 1 |
| Food and Beverage | $489.16 | 8 |
| Travel and Lodging | $439.52 | 1 |
| Education | $156.97 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $4,506.55 | 8 |
| Astellas Pharma US Inc | $156.97 | 3 |
| ABBVIE INC. | $132.13 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $125.00 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105264403 | CMS |
| ABBVIE INC. | $7.13 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105264407 | CMS |
| Astellas Pharma US Inc | $34.99 | 02/27/2024 | Education | Undisputed | 01/23/2026 | 1139344008 | CMS |
| Astellas Pharma US Inc | $86.99 | 11/04/2024 | Education | Undisputed | 01/23/2026 | 1139412897 | CMS |
| Astellas Pharma US Inc | $34.99 | 11/14/2024 | Education | Undisputed | 01/23/2026 | 1139413155 | CMS |
| Gilead Sciences, Inc. | $41.15 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133835248 | CMS |
| Gilead Sciences, Inc. | $58.47 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133835250 | CMS |
| Gilead Sciences, Inc. | $135.00 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133835252 | CMS |
| Gilead Sciences, Inc. | $439.52 | 09/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1133870214 | CMS |
| Gilead Sciences, Inc. | $9.82 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133835254 | CMS |
| Gilead Sciences, Inc. | $3,710.00 | 10/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133600271 | CMS |
| Gilead Sciences, Inc. | $93.11 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133835256 | CMS |
| Gilead Sciences, Inc. | $19.48 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133835258 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.